Carbone, Federico https://orcid.org/0000-0003-2957-4078
Grossi, Francesco
Bonaventura, Aldo
Vecchié, Alessandra
Minetti, Silvia
Bardi, Nicholas
Elia, Edoardo
Ansaldo, Anna Maria
Ferrara, Daniele
Rijavec, Erika
Dal Bello, Maria Giovanna
Biello, Federica
Rossi, Giovanni
Tagliamento, Marco
Alama, Angela
Coco, Simona
Spallarossa, Paolo
Dallegri, Franco
Genova, Carlo
Montecucco, Fabrizio
Funding for this research was provided by:
Ministero della Salute
Article History
Received: 12 April 2019
Accepted: 26 July 2019
First Online: 2 August 2019
Compliance with ethical standards
:
: Francesco Grossi has consulting/advisory relationship with and received honoraria from Bristol-Myers Squibb, Merck Sharp & Dohme, and Pierre Fabre and has consulting/advisory relationship with AstraZeneca and Roche. Carlo Genova received honoraria from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers-Squibb. Erika Rijavec received honoraria from Bristol-Myers Squibb (H). Paolo Spallarossa has consulting/advisory relationship with Incyte, Teva, Bristol-Myers Squibb and received honoraria from Incyte, Teva and Servier. The other authors indicated no financial relationship.